海外の子宮摘出術のベスト医師 — ページ4

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.

李懐芳医師は、婦人科腫瘍、骨盤底障害、および低侵襲婦人科手術を専門としています。10,000件以上の低侵襲手術と5,000件以上の骨盤底修復術を執刀してきました。腹腔鏡下および子宮鏡下でのがん手術も行っています。また、骨盤臓器脱や尿失禁に対する再建手術も実施しており、全国学会で手術手技を実演しています。

学術的役割：骨盤底機能障害グループ（CMA OBGYN）の全国メンバー。上海産婦人科医師会骨盤底グループ副代表。上海婦人科品質管理パネルの専門家。第12次五カ年計画に参加。現在は、骨盤底用生分解性メッシュに関する第14次五カ年計画のサブプロジェクトを主導しています。出版物：240本以上の論文（SCI 50本以上を含む）。同済大学の教科書共著者であり、50名以上の指導学生を持つ指導教官。受賞歴には、上海医学科学技術賞、中国母子保健科学技術賞、および2006年、2012年、2015年の骨盤底再建に関する賞などがあります。

ヤイール・バー博士は、シェバ医療センターの癌センターの副所長であり、胸部腫瘍内科医です。進行非小細胞肺癌の治療において、個別化免疫療法および標的療法を専門としています。分子生物学の博士号（PhD）を取得しており、免疫療法耐性に焦点を当てた研究室を主導しています。

• イスラエル肺癌グループの議長。
• 腫瘍内科および放射線腫瘍学の専門医認定を取得。
• 世界トップ10にランクされるシェバ医療センターで患者を治療。
• 分子・遺伝子プロファイリングを用いて、精密な癌治療計画を作成。

ラーナン・バーガー博士は、シェバ医療センターがんセンターのセンター長です。2025年にはForbesイスラエルの「ベストドクター」リストに選出されました。バーガー博士は泌尿器腫瘍学を専門とし、複雑な前立腺腫瘍への放射線治療を行っています。ダナ・ファーバー/ハーバードがん研究所で博士研究員としてのフェローシップを修了しました。

• 分子腫瘍学に焦点を当てた臨床研究ユニットを統括。
• 前立腺がんとBRCA変異に関する20本以上の査読付き論文の共著者。
• 米国臨床腫瘍学会（ASCO）会員。
• 世界トップ10にランクされる病院で全身療法および放射線療法を実施。

SERGSにより2つのロボットプラットフォームを使用して手術を行う認定を受けた最初の婦人科医であるポール・スタンチュ博士は、ポンデラス・アカデミック病院で低侵襲子宮全摘出術を専門としています。

• 婦人科腫瘍学およびロボット手術のサブスペシャリスト
• ロイヤル・マーズデン病院およびその他の著名なセンターで研修
• 若年がん患者のための複雑な妊孕性温存手術を実施
• 革新的な技術に関する多数の科学論文の著者

サムスン医療センターで婦人科腫瘍学を専門とするキム・テジュンは、子宮摘出術における精度に重点を置いています。

• 女性の健康のための腫瘍婦人科の専門家
• サムスン医療センターで診療

リー医師は腫瘍婦人科を専門とし、サムスン医療センターで子宮摘出術を必要とする患者への包括的なケアに注力しています。

• 低侵襲手術技術の専門家
• 術後の患者の生活の質の維持に尽力
• 韓国有数の医療機関に勤務

ギラッド・ベン・バルーフ教授はアスタ・メディカルセンターの腫瘍婦人科を専門とし、複雑な婦人科手術に注力しています。

• 長年の専門的経験を持つ腫瘍婦人科の専門家
• 婦人科疾患に対する高度な外科手術技術を実施
• 主要な医療施設であるアスタ・メディカルセンターに勤務

内視鏡および腹腔鏡下子宮摘出術の専門医 – コーエン医師は、アシュタ・メディカル・センターにて低侵襲手術に注力しています。

• 高度な外科的手法に精通した婦人科医
• 腹腔鏡技術を用いた手術を実施
• イスラエル有数の私立病院に勤務

産婦人科および婦人科腫瘍学の専門医であるアムノン医師は、ランバム医療センターにおける子宮摘出術において専門的な知見を提供します。

• 産科と婦人科腫瘍学の両方を専門とする
• 主要な医療機関であるランバム医療センターに勤務
• 一般婦人科と高度な腫瘍学のトレーニングを組み合わせている

レビンスタイン医師は、ランバム医療センターで産婦人科を専門としています。

• 子宮摘出術の専門家
• 患者中心のケアに重点を置いている
• 主要な医療センターで勤務

アミ・フィッシュマン教授は、ヘルツリヤ・メディカル・センターにて婦人科腫瘍学の腹腔鏡下手術および内視鏡手術を専門としています。

• ヘルツリヤ・メディカル・センターの主要な婦人科腫瘍専門医兼外科医
• メイル・メディカル・センター産婦人科部長
• 子宮、子宮頸部、卵巣の疾患を専門とする

フスライン教授は、オーストリア屈指の医療センターであるウィーン総合病院の産婦人科部門を率いています。

• 高度な婦人科手術を専門とする
• 低侵襲手術の専門知識を持つ
• 大規模な教育病院で複雑な症例を監督している

ユリア・コチェット医師は、17年の経験を持つ産婦人科医および生殖医療専門医であり、第一級の専門資格を有しています。ウクライナ生殖医療協会（UARM）および欧州ヒト生殖・発生学会（ESHRE）の会員です。生殖補助医療、超音波診断、子宮卵管造影、子宮鏡検査、腹腔鏡検査、ラジオ波手術、および子宮疾患や性感染症の治療において専門知識を持っています。国際的なセミナーや会議への参加経験も豊富です。

イリーナ・バベンコ医師は、16年の経験を持つ不妊治療の専門家であり、ピロゴフ記念国立医科大学医学部で博士号（PhD）および医学博士号（MD）を取得しています。生殖補助医療、不妊症および流産の治療、手術的婦人科、性感染症の治療、婦人科における内視鏡手術、超音波診断を専門としています。ウクライナ生殖医療協会および欧州ヒト生殖・発生学会の会員です。

産婦人科専門医として24 年以上の経験を持つドゥリオティス医師は、Babydustクリニックにて個別の不妊治療に注力しています。

• 不妊症および生殖補助医療のサブスペシャリスト
• 英国王立産婦人科医協会（RCOG）会員
• 海外の患者様にも手頃な価格で不妊治療を提供

イスタンブール・アルトゥンバシュ大学の助教授であり、20本以上の論文を発表。シスマノグル医師は、学術研究と生殖医療における臨床経験を融合させています。

• 体外受精（IVF）、産科、不妊手術を専門とする
• 欧州ヒト生殖医学会（ESHRE）会員
• トルコのメディアで生殖医療の専門家として頻繁に取り上げられている
• 多言語対応チームが国際的な患者をサポート

シタナン・パヌヌンパ医師は、バンコクのサイアム・ファーティリティの医療ディレクターです。年間300件以上の体外受精（IVF）および顕微授精（ICSI）サイクルを実施しています。また、年間200件以上の婦人科腹腔鏡手術も行っています。パヌヌンパ医師は、スペインでヒト補助生殖技術のバイオテクノロジーの修士号を取得しています。

• ラマティボディ病院による生殖医療の認定医。
• 米国生殖医学会（ASRM）会員。
• 欧州ヒト生殖・発生学会（ESHRE）会員。
• 子宮内膜症、多嚢胞性卵巣症候群、子宮筋腫などの疾患を治療。

腹腔鏡下子宮全摘術の専門医 – リー医師は、嘉泉大学ギル医療センターにて低侵襲手術に注力しています。

• 腹腔鏡手術の専門知識を持つ婦人科腫瘍専門医
• より小さな切開で子宮を摘出し、早期回復を実現
• 韓国の主要な大学医療センターに勤務

レイエス医師は、生殖生物学に重点を置いた産婦人科を専門としており、その研究には不妊症や妊娠転帰に関する重要な出版物が含まれています。

• アンヘレス・デル・ペドレガル病院にて生殖生物学のサブスペシャリティを取得
• メキシコ産婦人科学会会員
• キンタナ・ロー州産婦人科カレッジの科学コーディネーター
• 筋腫核出術および体外受精（IVF）の妊娠率に関する研究を発表